Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD
NCT05639738 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2022-12-06
Summary
The aim of the study is to collect different parameters (clinical, biological and biometrological) of Atopic Dermatitis (AD) in order to identify which factors are modified during the flare-up phase.
Conditions
- Dermatitis, Atopic
Interventions
- OTHER
-
Clinical and instrumental measurements
* Clinical evaluations * Non-invasive instrumental measurements * Subject's evaluations
Sponsors & Collaborators
-
Pierre Fabre Dermo Cosmetique
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-08
- Primary Completion
- 2022-06-15
- Completion
- 2022-06-15
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study
NCT07166497 ·Status: COMPLETED
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
NCT05139836 ·Status: ACTIVE_NOT_RECRUITING
-
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
NCT06837454 ·Status: RECRUITING
-
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
NCT02087943 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
NCT03389893 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
NCT03849716 ·Status: ACTIVE_NOT_RECRUITING
-
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis
NCT02369432 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
NCT05614817 ·Status: WITHDRAWN ·Phase: PHASE3
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
Targeted Investigation of Microbiome Elimination
NCT05177328 ·Status: TERMINATED ·Phase: PHASE1
-
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
NCT03915496 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
NCT02395133 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
NCT04345367 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06815380 ·Status: RECRUITING
-
A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD Patients
NCT04699695 ·Status: UNKNOWN
-
Staphylococcus Aureus in Atopic Dermatitis Immunopathology
NCT04715087 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03568318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis
NCT04761978 ·Status: WITHDRAWN
-
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
NCT05399368 ·Status: TERMINATED ·Phase: PHASE2
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus Placebo
NCT06763939 ·Status: COMPLETED
-
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT02277743 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2